上海医药(02607.HK)：盐酸曲马多注射液通过仿制药一致性评价

Core Viewpoint - Shanghai Pharmaceuticals (02607.HK) announced that its subsidiary, Shanghai Hefeng Pharmaceutical Co., Ltd. (referred to as "Hefeng"), has received the "Drug Supplement Application Approval Notice" from the National Medical Products Administration for its Tramadol Hydrochloride Injection, which has passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1 - The Tramadol Hydrochloride Injection is primarily used for the treatment of moderate to severe pain [1]